Industry

U.S. FDA issues two observations to Cipla arm InvaGen’s U.S. facility

The observations followed a pre-approval inspection (PAI) by the regulator at InvaGen's manufacturing facility in Hauppauge, Long Island, New York

nrinewsnrinews
Feb 10, 2026 - 11:40
 0  5
U.S. FDA issues two observations to Cipla arm InvaGen’s U.S. facility
The observations followed a pre-approval inspection (PAI) by the regulator at InvaGen's manufacturing facility in Hauppauge, Long Island, New York
Read More

Tags:

Previous Article

Nick reacts to brother Joe's video 'doing drugs'

Next Article

'Don't think ex-Army chief will lie': Rahul Gandhi reacts to publisher's stateme...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

nrinews
nrinews

Related Posts

CCPA issues notice to Uber over 'Advance Tip' feature for faster service

CCPA issues notice to Uber over 'Advance Tip' feature f...

nrinews May 21, 2025  0  18

Industrialist Sunjay Kapur, Karisma Kapoor’s ex-husband, passes away

Industrialist Sunjay Kapur, Karisma Kapoor’s ex-husband...

nrinews Jun 13, 2025  0  7

Why were IndiGo operations disrupted? | Explained

Why were IndiGo operations disrupted? | Explained

nrinews Dec 16, 2025  0  4